BRUSSELS– Spiros Drosos has joined Covington's Life Sciences Practice based in the firm’s Brussels office.
Spiros served as the Head of Litigation at the European Medicines Agency between 2020 and 2025. As the Agency’s lead litigator, Spiros represented the EMA in all major cases before the EU General Court and the Court of Justice (CJEU) spanning a wide range of complex regulatory issues, including data exclusivity, clinical trial transparency, orphan drug market exclusivity, regulatory actions, conflicts of interest and questions at the intersection of pharmaceutical and competition law.
Alongside litigation, Spiros played a pivotal advisory role within the EMA. He provided strategic guidance on regulatory compliance across the entire lifecycle of medicines and medical devices, from early-stage clinical development and marketing authorization applications to post-approval safety monitoring and enforcement.
In addition, over the past five years, Spiros served as the exclusive legal advisor to the Committee on Orphan Medicinal Products, while advising all EMA committees on complex matters of EU law, as well as on compliance with EU public and administrative law requirements.
Mike Labson, a co-chair of Covington's Life Sciences practice, said: “Spiros further strengthens our leadership in EU regulatory and litigation matters as they affect companies in the life sciences sector. Drawing on more than a decade of frontline experience at the European Medicines Agency, Spiros combines the experience of a seasoned litigator with the strategic insight of a senior regulatory advisor. His deep understanding of EMA processes and EU law will be a decisive asset for life sciences clients navigating regulatory complexity.”
Peter Bogaert, co-chair of Covington’s European Food, Drug & Device practice, added: “We are very excited to welcome Spiros to the team. In an era of accelerating legislative reform, increasing regulatory complexity, and rigorous enforcement across Europe, Spiros’ expertise empowers clients to anticipate change, ensure compliance, and thrive in an evolving market.”
“We are thrilled with Spiros’ decision to join Covington,” said Grant Castle, a co-chair of Covington's Life Sciences practice and co-chair of the firm's European Food, Drug & Device Practice. “His comprehensive understanding of the internal workings of the EMA and its Committees, and how they impact the product lifecycle – for both drugs and associated medical devices and diagnostics – enables him to anticipate regulatory challenges and craft long-term regulatory compliance strategies. This hands-on experience will be invaluable to our clients, particularly those operating across jurisdictions.”
Spiros commented: “In the life sciences industry, Covington’s name is synonymous with integrity, expertise and collegiality. I am very excited to be joining this world-class team, and look forward to bringing my expertise to bear when it comes to a variety of regulatory, litigation and policy issues affecting companies in the life sciences and medical device sectors.”
Spiros holds a Master of Laws in European and International Law from the European University Institute, Florence, Italy, a Master of Laws in Environmental Law and Policy from the University College London, UK, and a Bachelor of Laws from the University of Athens Law School, Greece. He is admitted to practice in Greece and Brussels.
Spiros was a visiting scholar at the UC Berkeley School of Law, California, U.S. (2012) He speaks English, German, French and Greek.
Back
